Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium intake reduction refers to strategies or interventions aimed at lowering dietary sodium consumption in individuals or populations. Sodium is an essential nutrient but excessive intake is associated with increased risk of hypertension, cardiovascular diseases, and potentially kidney diseases or stroke[6][7]. Most sodium in the diet comes from processed foods. Reducing sodium intake can lower blood pressure, especially in salt-sensitive individuals, but is not a molecular or protein target for drugs. Regulatory and behavioral interventions are the main approaches. Biological effects of sodium reduction include lowered blood pressure, changes in some blood metabolites, and compensatory activation of hormonal pathways including the renin-angiotensin-aldosterone system[1][4][7]. Some controversies exist over the risks of too-low sodium intake and population-wide recommendations[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium intake reduction.